LV11728A - Farmaceitiska kompozicija - Google Patents

Farmaceitiska kompozicija

Info

Publication number
LV11728A
LV11728A LV950256A LV950256A LV11728A LV 11728 A LV11728 A LV 11728A LV 950256 A LV950256 A LV 950256A LV 950256 A LV950256 A LV 950256A LV 11728 A LV11728 A LV 11728A
Authority
LV
Latvia
Prior art keywords
pct
pharmaceutical composition
date feb
sec
pub
Prior art date
Application number
LV950256A
Other languages
English (en)
Other versions
LV11728B (en
Inventor
Ivars Kalvins
Maris Veveris
Original Assignee
Ivars Kalvins
Maris Veveris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars Kalvins, Maris Veveris filed Critical Ivars Kalvins
Priority to LVP-95-256A priority Critical patent/LV11728B/lv
Priority to DE69627160T priority patent/DE69627160T2/de
Priority to CA002229228A priority patent/CA2229228C/en
Priority to UA98020919A priority patent/UA44330C2/uk
Priority to US09/011,380 priority patent/US5859056A/en
Priority to JP09509171A priority patent/JP3072858B2/ja
Priority to EP96927931A priority patent/EP0845986B1/en
Priority to ES96927931T priority patent/ES2196167T3/es
Priority to AT96927931T priority patent/ATE235901T1/de
Priority to PCT/LV1996/000002 priority patent/WO1997006794A1/en
Priority to EA199800160A priority patent/EA000472B1/ru
Publication of LV11728A publication Critical patent/LV11728A/lv
Publication of LV11728B publication Critical patent/LV11728B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
LVP-95-256A 1995-08-21 1995-08-21 Pharmaceutical composition LV11728B (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
LVP-95-256A LV11728B (en) 1995-08-21 1995-08-21 Pharmaceutical composition
DE69627160T DE69627160T2 (de) 1995-08-21 1996-08-20 Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen
CA002229228A CA2229228C (en) 1995-08-21 1996-08-20 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine
UA98020919A UA44330C2 (uk) 1995-08-21 1996-08-20 Фармацевтична композиція для лікування серцево-судинних захворювань
US09/011,380 US5859056A (en) 1995-08-21 1996-08-20 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium)propionate and γ-butyrobetaine
JP09509171A JP3072858B2 (ja) 1995-08-21 1996-08-20 ３−（２，２，２−トリメチルヒドラジニウム）プロピオネートとガンマ−ブチロベタインを含有する心臓血管疾患の治療のための医薬組成物
EP96927931A EP0845986B1 (en) 1995-08-21 1996-08-20 Pharmaceutical composition containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine for the treatment of cardiovascular diseases
ES96927931T ES2196167T3 (es) 1995-08-21 1996-08-20 Composicion farmaceutica que contiene propionato de 3-(2,2,2-trimetilhidrazinio) y gamma-butirobetaina para el tratamiento de enfermedades cardiovasculares.
AT96927931T ATE235901T1 (de) 1995-08-21 1996-08-20 Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
PCT/LV1996/000002 WO1997006794A1 (en) 1995-08-21 1996-08-20 Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium) propionate and gamma-butyrobetaine
EA199800160A EA000472B1 (ru) 1995-08-21 1996-08-20 Фармацевтическая композиция для лечения сердечно-сосудистых заболеваний, содержащая 3-(2,2,2-триметилгидразиний)пропионат и гамма-бутиробетаин

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-95-256A LV11728B (en) 1995-08-21 1995-08-21 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
LV11728A true LV11728A (lv) 1997-04-20
LV11728B LV11728B (en) 1997-08-20

Family

ID=19736013

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-256A LV11728B (en) 1995-08-21 1995-08-21 Pharmaceutical composition

Country Status (11)

Country Link
US (1) US5859056A (lv)
EP (1) EP0845986B1 (lv)
JP (1) JP3072858B2 (lv)
AT (1) ATE235901T1 (lv)
CA (1) CA2229228C (lv)
DE (1) DE69627160T2 (lv)
EA (1) EA000472B1 (lv)
ES (1) ES2196167T3 (lv)
LV (1) LV11728B (lv)
UA (1) UA44330C2 (lv)
WO (1) WO1997006794A1 (lv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV12491B (lv) * 1998-10-29 2000-12-20 Ivars KALVIŅŠ Farmaceitiska kompozīcija
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
LV12979B (en) 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
JP4390134B2 (ja) 2003-11-05 2009-12-24 日本精工株式会社 ステアリング装置
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
LV14274B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldoniju saturošs kombinēts medicīniskais produkts
WO2010149654A1 (en) * 2009-06-25 2010-12-29 Grindeks, A Joint Stock Company Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
LV14345B (lv) * 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
EA023547B1 (ru) * 2011-04-27 2016-06-30 Гриндекс, Джоинт Сток Кампани Применение солей 3-карбокси-n-этил-n,n-диметилпропан-1-аммония при лечении сердечно-сосудистого заболевания
BR112013027075A2 (pt) 2011-04-27 2016-12-27 Grindeks Jsc 4-[(haloalquil)-(dsimetil)-amônio] butanoatos, processos de preparação e seus usos no tratamento de doenças cardiovasculares
LV14848B (lv) * 2012-10-25 2015-06-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai
GB201315321D0 (en) 2013-08-28 2013-10-09 Koninklijke Nederlandse Akademie Van Wetenschappen Transduction Buffer
CN112180013B (zh) * 2020-09-29 2022-11-15 上海脉示生物技术有限公司 用于心肌梗死诊断的肠道微生物代谢标志物组合物及其检测方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
IT1210935B (it) * 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.

Also Published As

Publication number Publication date
EA199800160A1 (ru) 1998-08-27
US5859056A (en) 1999-01-12
DE69627160T2 (de) 2004-02-12
EA000472B1 (ru) 1999-08-26
UA44330C2 (uk) 2002-02-15
CA2229228A1 (en) 1997-02-27
LV11728B (en) 1997-08-20
EP0845986B1 (en) 2003-04-02
ATE235901T1 (de) 2003-04-15
DE69627160D1 (de) 2003-05-08
JP3072858B2 (ja) 2000-08-07
ES2196167T3 (es) 2003-12-16
EP0845986A1 (en) 1998-06-10
CA2229228C (en) 2008-07-08
WO1997006794A1 (en) 1997-02-27
JPH10512286A (ja) 1998-11-24

Similar Documents

Publication Publication Date Title
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
ATE206611T1 (de) Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung
LV11728A (lv) Farmaceitiska kompozicija
MY132705A (en) Novel compounds with analgesic effect
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
NO954996D0 (no) Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS
YU49026B (sh) UPOTREBA 17 Гџ -(N-TERC-BUTILKARBAMOIL)-4-AZA-5-ALFA-ANDROST-1-3-ON ZA PROIZVODNJU LEKA ZA TRETIRANJE ANDROGENE ALOPECIJE
GEP20032958B (en) Adenosine Derivatives
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
MY113062A (en) Amide derivatives and their therapeutic use
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
ATE360428T1 (de) Analgetisches arzneimittel
FI934680A (fi) Arylmorfolin, framstaellning och anvaending
TW261532B (lv)
DE69713067T2 (de) Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
GR3034062T3 (en) Utilization of efaroxan and derivatives thereof for the preparation of a medicament intended to the treatment of parkinson disease
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
EP0784973A3 (en) Quinoxaline derivatives for treating tinnitus
SE9603284D0 (sv) New compounds
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.